Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wednesday, September 7, 2011 - 9:54am
tags:
Medicare, off-label, Avastin, Roche, Genentech, age-related macular degeneration
Sanofi’s PowerPoint of Doom Shows 9,500 Layoffs by the End of the Year
BNET Pharma
Wednesday, September 7, 2011 - 9:51am
tags:
Sanofi, layoffs
1 Reason the Street Should Expect Big Things From ViroPharma
Motley Fool
Wednesday, September 7, 2011 - 9:49am
tags:
ViroPharma, Gilead, Cubist Pharmaceuticals, Salix
BioDelivery Sciences reports positive Phase 1 drug results
Bizjournals.com
Wednesday, September 7, 2011 - 9:48am
tags:
BioDelivery Sciences, BEMA Buprenorphine/Naloxone, drug abuse
Biogen will buy Italy, Switzerland joint ventures
Yahoo/AP
Wednesday, September 7, 2011 - 9:46am
tags:
Biogen Idec, Italy, Switzerland, Dompe Group
ViroPharma receives European Union approval for pediatric epileptic seizure treatment
Yahoo/AP
Wednesday, September 7, 2011 - 9:45am
tags:
Europe, ViroPharma, epilepsy
Amag-Allos Merger in Jeopardy
TheStreet.com
Wednesday, September 7, 2011 - 9:43am
tags:
Allos, Amag Pharmaceuticals, M&A
Roche Signs First Alzheimer's Deal Of 2011 As Crucial Progress Awaited
Seeking Alpha
Wednesday, September 7, 2011 - 9:34am
tags:
Roche, Alzheimer's disease, Ranbaxy, Elan, JNJ, Eli Lilly, Pfizer
J&J Failed to Warn About Tendon Risk From Antibiotic Levaquin, Lawyer Says
Bloomberg
Tuesday, September 6, 2011 - 5:57pm
tags:
Levaquin, JNJ, antibiotics
Dendreon's Provenge Greediness Leaves Stock Messy, Shareholders Unhappy
Minyanville
Tuesday, September 6, 2011 - 5:55pm
tags:
Provenge, shareholders, prostate cancer, Dendreon
Abbott Laboratories Passes This Key Test
Motley Fool
Tuesday, September 6, 2011 - 5:54pm
tags:
Abbott Laboratories
Pfizer Inc.’s tender offer for Icagen successful
Bizjournals.com
Tuesday, September 6, 2011 - 5:52pm
tags:
tender offer, Pfizer, Icagen
Investors Take Aim at J&J’s $150M CEO
BNET Pharma
Tuesday, September 6, 2011 - 1:06pm
tags:
investors, JNJ, William Weldon, Pharma CEOs
Dendreon nixes Provenge supply deal with GSK
Fierce Pharma
Tuesday, September 6, 2011 - 1:04pm
tags:
prostate cancer, GSK, Dendreon, Provenge
Amgen Biotech Diversity: Pipeline For The Future, Stock Stability For Income
Seeking Alpha
Tuesday, September 6, 2011 - 12:45pm
tags:
Amgen, PCSK9 inhibitor
Pharmasset climbs after study result released
Yahoo/AP
Tuesday, September 6, 2011 - 12:44pm
tags:
hepatitis C, Pharmasset, PSI-7977
A Grieving J&J Employee And Cubicle Photos
Pharmalot
Tuesday, September 6, 2011 - 12:22pm
tags:
JNJ
Anacor, GlaxoSmithKline further R&D collaboration
Bizjournals.com
Tuesday, September 6, 2011 - 12:19pm
tags:
R&D, GSK, Anacor
Adolor buys back Entereg rights from GlaxoSmithKline
Bizjournals.com
Tuesday, September 6, 2011 - 12:19pm
tags:
GSK, Adolor, Entereg
Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Motley Fool
Tuesday, September 6, 2011 - 12:17pm
tags:
Sanofi, Genzyme, Kynamro, Visamerin/Mulsevo, Zaltrap, Lemtrada, Aubagio, Lyxumia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.